AZN Search Results - QuantumOnline.com

Become a QuantumOnline Supporter!

Quick Search
Hint: For Preferreds Try XXX-D
Hint: For Securites No Longer Traded, Try XXX* or XXX-D*
Hint: For All Securites of XXX, Search XXX, and click Find All Related Securities link.
Top Banner


Register for QuantumOnline.com

AstraZeneca plc ADR
Ticker Symbol: AZN     CUSIP: 046353108     Exchange: NGS

Company's Online Profile
BUSINESS:  AstraZeneca plc is biopharmaceutical company focusing on six Therapy Areas: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology and Respiratory & Inflammation. It owns and operates R&D, production and marketing facilities worldwide.

IPO - 1/1/1900
ADR with an ADR ratio of 1:2
Large Cap Stock -   Market Value $ Million
Click for current AZN price quote from the NASDAQ

Yahoo News Summary for AZN
YAHOO! Profile for AZN
Yahoo Detailed Quote
MarketWatch Quote
MSN Company Report for AZN

Company's Online Information Links
HOME PAGE:     https://www.astrazeneca.com/
Company's Investor Relations Information Goto Investor Relations Information
Company's Online News Releases Goto News Releases
Online Company Profile Goto Online Profile

Company's Online SEC EDGAR Filings
Company's SEC EDGAR Filings Goto SEC Filings

Company's Email Address Links
Email Address CorporateAccess@astrazeneca.com

Foreign Address and Phone Numbers
Address:   1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA
Main Phone Number +44 20 3749 5000
Fax Number +44 1223 352 858
Inv Rel Phone Number   Andy Barnett +44 20 7604 8123

Address and Phone Numbers
U.S. Representative N.A.
Address:   1800 Concord Pike, P.O. Box 15437, Wilmington, DE 19850
Main Phone Number 302-886-3000
Fax Number 302-886-2972
Investor Relations 866-381-7277
Toll Free Phone Number 866-381-7277
CEO - Pascal Soriot CFO - Aradhana Sarin

Find a problem? Please use our Feedback Page or Email us.
Have you filled out our Guestbook? If not, please do.




QuantumOnline.com
Copyright © 1997 - 2025 QuantumOnline.com. All rights reserved.
Latest Update: